BDX

Becton, Dickinson and Company

236.25 USD
-0.05 (-0.02%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Becton, Dickinson and Company stock is up 1.33% since 30 days ago. The dividend yield is 1.63% and its next earnings date is Aug 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 49 May’s closed higher than April. In the last 10 Unusual Options Trades, there were 2 PUTs, 8 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
03 May 13:40 17 Jan, 2025 240.00 PUT 20 290
03 May 17:34 17 May, 2024 235.00 CALL 206 1190
08 May 18:23 17 May, 2024 240.00 CALL 418 1632
09 May 14:16 17 May, 2024 235.00 CALL 140 1556
09 May 14:16 17 May, 2024 235.00 CALL 85 1556
14 May 14:38 19 Jul, 2024 230.00 CALL 100 3
15 May 13:32 20 Sep, 2024 235.00 CALL 25 42
15 May 13:55 19 Jul, 2024 260.00 PUT 39 0
16 May 15:09 21 Jun, 2024 240.00 CALL 155 435
17 May 19:24 21 Jun, 2024 235.00 CALL 450 135

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis cathetters, vascular care and preparation products, needle-free IV connectors and extensions sets, syringes, pen needles, and other products for diabetes. Its Life Sciences segment provides specimen and blood collection products; other surgical products.